Trials / Unknown
UnknownNCT05836441
Improved Phototherapy in Patients With Vitiligo
A Multicenter, Randomized, Open, Parallel Controlled Clinical Study Evaluating the Efficacy and Safety of Improved Phototherapy in Patients With Vitiligo
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
Vitiligo is a common acquired depigmentation skin and mucosal disease in dermatology, with or without white hair. Vitiligo with white hair is difficult to treat. Phototherapy and topical therapy are the first line treatment methods for vitiligo. The peripheral leukoplakia irradiation of phototherapy covers the central area of the leukoplakia and performs phototherapy on the edge of the leukoplakia and surrounding normal skin. This study aims to compare the efficacy and safety of peripheral leukoplakia ultraviolet family phototherapy and leukoplakia family combination in the treatment of vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Exposure to white patches | Exposure to white patches |
| RADIATION | Exposure to edge of white patches and normal skin around white patches | Exposure to edge of white patches and normal skin around white patches |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-07-30
- Completion
- 2023-12-30
- First posted
- 2023-05-01
- Last updated
- 2023-05-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05836441. Inclusion in this directory is not an endorsement.